Tenon Medical (TNON) 10% Owner HRT FINANCIAL LP Sells & Buys

What Happened

• HRT FINANCIAL LP, listed as a 10% owner of Tenon Medical (TNON), executed multiple open-market transactions from Sept 8–10, 2026. The filings show total sales of 125,925 shares for about $538,645 and total purchases of 107,140 shares for about $382,985 — a net disposition of roughly $155,660 (more sold than bought).
• Notable individual trades: sales include 50,395 sh @ $2.61 ($131,531), 9,948 sh @ $4.27 ($42,478), and 65,582 sh @ $5.56 ($364,636). Purchases include 39,508 sh @ $3.40 ($134,327), 31,227 sh @ $2.92 ($91,183), 28,267 sh @ $4.02 ($113,633), 8,431 sh @ $4.92 ($41,481), and a small 707‑share buy @ $3.34 ($2,361).
• These were open‑market purchases and sales. Purchases can be seen as a more bullish signal than routine sales, but HRT FINANCIAL LP both bought and sold during this short window and overall was a net seller.

Key Details

• Transaction dates: Sept 8–10, 2026 (filed on Form 4: Sept 11, 2026).
• Aggregate sold: 125,925 shares for ~$538,645. Aggregate bought: 107,140 shares for ~$382,985. Net proceed ≈ $155,660 (sales > purchases).
• Individual trade highlights: 50,395 sh @ $2.61; 65,582 sh @ $5.56 (largest sale); 39,508 sh @ $3.40; 28,267 sh @ $4.02 (larger buys listed above).
• Shares owned after the transactions: not provided in the excerpt supplied (check the full EDGAR filing for post-transaction holdings).
• Footnotes: F1 — issuer/SEC can request full breakdown of how many shares were transacted at each separate price. F2 — indicates that some of the reported sales resulted in short sales.
• Filing timing: Form 4 filed 2026-09-11 for trades from 2026-09-08 to 2026-09-10. Form 4s are generally due within two business days of each transaction — consult the EDGAR record for any timeliness flags.

Context

• HRT FINANCIAL LP is a large (10%) shareholder — institutional/trust-level trading behavior differs from an officer/director trade. Institutional buys can signal conviction, but mixture of buys and larger sells here results in a net sale.
• No derivatives, option exercises, grants, or gifts are reported in this excerpt — these were direct purchases (P) and sales (S) in the open market.
• For full detail (per‑price breakdowns, exact post-transaction ownership, and any short-sale specifics), refer to the complete Form 4 on SEC EDGAR.